Are Mexican Equities Ready To Bounce?
Mexican equities have been experiencing an awful 2014, with the iShares Mexico ETF (EWW) off nearly 12% YTD. The emerging market space as a...
Biotech Bubble? The Nervous Speculator’s Field Guide
By definition, any trend that becomes so axiomatic for the market that not participating seems obscene has entered its latter days.
Three weeks ago we...
Real Life Trading Lessons: Rules vs Conviction
I have tried to share real life trading lessons in previous columns, and this week's entire Ukraine-Crimea-Russia quick roller-coaster provided for another entry in...
The Best Of See It Market – February 2014
Investors dedicated most of the month of February to offsetting January's equities drubbing. It seems that bearish sentiment has been sensitive and tends to...
NASDAQ 100 Stalling Near Technical Barrier
Stocks managed an impressive upswing off their early February lows, rewarding those who continued to buy the dip. I stayed cautious throughout based on...
March Seasonality: Stocks And ETFs That Outperform In March
Last month, in order to generate some ideas for active investors, I put together a February seasonality post. Â The post got some great feedback,...
Price Surge: The Rise Of Soft Commodities In Early 2014
Just when everyone had written off the commodity sector as being a serial underperformer for the last two years, it has resurged in 2014...
Using Weekly Charts To Gain A Tactical Advantage
During stock market corrections / pullbacks in a mature bull market I tend to gravitate to stocks that are displaying constructive price action around...
BioShock: Why Biotech Bubble Fears Are On Solid Ground
What's left to be said about the quickening madness that has every appearance of spooling into a classic mania in Biotech stocks? Sean McLaughlin...
NASDAQ 100: Record “No Correction” Streak About to End
Forget 1929: maybe it's time to start comparing the current market to 1999 again.
Since hammering out a bottom 2.5 weeks ago, the NASDAQ 100...
